CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing new medicines, particularly chemotherapeutic drugs, by understanding their biological mechanisms. It aims to create a start-up that identifies target structures and interactions of small bioactive molecules with high precision.
Development of new medicines such as chemotherapeutic drugs requires a detailed understanding of their biological mechanism of action.
What are the desired and undesired interactions with biological molecules?
It is our goal to found a start-up company that will provide a solution to this challenge.
Using novel and ground-breaking approaches we can identify target structures and interaction partners of small bioactive molecules at an unmatched and unprecedented resolution. ERC PoC funding will b…
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
